Arkema Plans Polyamide 12 Capacity Expansion in China
To complement its major project in bio-based polyamide 11, French chemicals group, Arkema has announced a 25% expansion in its global polyamide 12 polymers production capacities, commercialised under the trademark Rilsamid, to support its customers’ strong demand in Asia.
This new capacity will be added at Arkema’s Changshu platform in China and is expected to come on stream by mid-2020. “This investment which represents several tens of millions of euros, will support the strong demand in growth applications such as cable protection, light-weighting (metal replacement) in automobiles, improved high performance sports shoes (running, soccer, etc.) and evolving applications in the consumer electronics segment. The mid-term growth rates in these applications are expected to exceed 7% per year in Asia,” the company said in a press note.
2026-10-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Arkema Triples Transparent Polyamide Capacity in Singapore: a Bet on Virtual Reality Growth or a Move to Strengthen Supply Resilience?
-
Arkema's New Singapore Plant Commences Operations, Tripling Polyamide Capacity
-
Arkema Divests PVC Additives Business to Focus Resources on High-Performance Materials Market
-
Arkema Invests $60 Million to Upgrade its US FluoroSpecialties Production Unit
-
Arkema Continues to Increase Investment in Singapore, Investing $20 Million to Build a Transparent Polyamide Plant
-
Arkema Receives ISCC PLUS Certification for Mass Balance of UV-LED-EB Resin Production
-
Arkema Announces Production of Bio-Based Performance Rheology Additives in Europe
-
Arkema Launches Acrylic Acid Purification Project
-
Arkema Invests $20 Million in North America to Increase PVDF Production Capacity by 15%
-
ALBIS to Distribute Arkema’s High-Performance Medical-Grade Polymers
Recommend Reading
-
Nylon Giant to Close Another European Plant, Cutting 140 Jobs
-
Biocon Weighs Merger of Biocon Biologics to Unlock Value
-
Semcorp's Hungarian Factory Ordered to Shut Down Over Pollution
-
argenx to Acquire Forte Biosciences for $2.2 Billion in Major Autoimmune Antibody Deal
-
Merck Nears Acquisition of Cidara to Strengthen Flu Prevention Arsenal
-
Business Society October 16, 2026 BDO Trend Analysis: High-Level Volatility
-
BDO Market Trends Primarily Consolidating
-
Business Society, October 16, 2026: Fuel Oil 180CST Trend Analysis – Volatility
-
Business Society October 16, 2026 MTBE Trend Analysis: Bearish Volatility
-
Business Society October 16, 2026 Petroleum Coke Trend Analysis: Volatility